+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Intravenous prostaglandin E1 in the treatment of venous ulcers--a double-blind, placebo-controlled trial



Intravenous prostaglandin E1 in the treatment of venous ulcers--a double-blind, placebo-controlled trial



Vasa. Supplementum 28: 39-43



To assess the clinical efficacy of i.v. PGE1 in the treatment of refractory venous ulcers a double-blind, placebo-controlled study was carried out. 42 patients were given at random either one i.v. infusion of 3 ampoules of Prostavasin (60 micrograms PGE1) or 3 ampoules of placebo (1940.1 micrograms alpha-CD) daily, soluted in 250 ml saline over 3 h. The treatment period was 6 weeks. In the PGE1 group (n = 20) there was a significant improvement in the ulcer status compared to placebo (n = 22) (p less than 0.001) being assessed by a detailed, multivariated score. Ulcers healed completely in 8 out of 20 patients on PGE1 (40%) compared to only 2 out of 22 patients on placebo (9%). Concomitant clinical symptoms improved accordingly. Whereas in the PGE1 group edema were completely resolved in 17 out of 20 patients (85%) this was the case in 7 out of 20 patients of the placebo group (35%). Calf cramps and eczema vanished in 80% and 87.5% respectively under PGE1, but only in 50% and 9% respectively under placebo. Parallel to this an increase of the tcPO2 in the ulcer area of a mean of 45.9% was observed. Throughout the whole treatment period no side effects were noted after PGE1 infusion.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040496593

Download citation: RISBibTeXText

PMID: 2692199


Related references

Randomised, double blind placebo controlled trial of pentoxifylline in the treatment of venous leg ulcers. BMJ 319(7214): 875-878, 1999

Treatment of venous ulcers with pentoxifylline: a 6-month randomized, double-blind, placebo controlled trial. Angiology 53(Suppl. 1): S45-S47, 2002

Treatment of venous ulcers with pentoxifylline: a 12-month, double-blind, placebo controlled trial. Microcirculation and healing. Angiology 53(Suppl. 1): S49-S51, 2002

Topical 5 methylthioadenosine mta in the treatment of chronic venous ulcers results of a double blind placebo p controlled clinical trial. European Journal of Clinical Investigation 20(2 Part 2): A17, 1990

Local therapy and treatment costs of chronic, venous leg ulcers with electrical stimulation (Dermapulse): a prospective, placebo controlled, double blind trial. Wound Repair and Regeneration 16(4): 480-487, 2008

Simvastatin as a novel therapeutic agent for venous ulcers: a randomized, double-blind, placebo-controlled trial. British Journal of Dermatology 170(5): 1151-1157, 2014

Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial. Lancet 380(9846): 977-985, 2012

A placebo-controlled, double-blind study of mesoglycan in the treatment of chronic venous ulcers. European Journal of Vascular and Endovascular Surgery 22(4): 365-372, 2001

Double-blind placebo-controlled study with topical 2% ketanserin ointment in the treatment of venous ulcers. Dermatologica 178(2): 98, 1989

Randomised, double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers. Thrombosis and Haemostasis 87(6): 947-952, 2002

Double blind placebo controlled study with topical 2 percent ketanserin ointment in the treatment of venous ulcers. Dermatologica (Basel) 178(2): 98-102, 1989

Antimicrobial treatment of venous leg ulcers a double blind randomized placebo controlled comparison of 12 weeks treatment with ciprofloxacin and trimethoprim. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 32: 362, 1992

A portable pulsed electromagnetic field (PEMF) device to enhance healing of recalcitrant venous ulcers: a double-blind, placebo-controlled clinical trial. British Journal of Dermatology 127(2): 147-154, 1992

Bicitropeptide powder and placebo in the treatment of duodenal ulcers. A double-blind endoscopically controlled clinical trial. South African Medical Journal 61(7): 234-235, 1982

Misoprostol a synthetic prostaglandin e 1 analog in the treatment of duodenal ulcers a double blind cimetidine controlled trial. South African Medical Journal 67(9): 321-324, 1985